nodes	percent_of_prediction	percent_of_DWPC	metapath
Moclobemide—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0326	0.0419	CbGbCtD
Moclobemide—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0306	0.0394	CbGbCtD
Moclobemide—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0301	0.0387	CbGbCtD
Moclobemide—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0283	0.0364	CbGbCtD
Moclobemide—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0283	0.0364	CbGbCtD
Moclobemide—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0277	0.0357	CbGbCtD
Moclobemide—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0277	0.0357	CbGbCtD
Moclobemide—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0271	0.0349	CbGbCtD
Moclobemide—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0256	0.0329	CbGbCtD
Moclobemide—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0255	0.0328	CbGbCtD
Moclobemide—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0255	0.0328	CbGbCtD
Moclobemide—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0248	0.0319	CbGbCtD
Moclobemide—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0239	0.0308	CbGbCtD
Moclobemide—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0233	0.03	CbGbCtD
Moclobemide—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0233	0.03	CbGbCtD
Moclobemide—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0232	0.0299	CbGbCtD
Moclobemide—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.023	0.0296	CbGbCtD
Moclobemide—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.023	0.0296	CbGbCtD
Moclobemide—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0214	0.0276	CbGbCtD
Moclobemide—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0211	0.0271	CbGbCtD
Moclobemide—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0211	0.0271	CbGbCtD
Moclobemide—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.021	0.027	CbGbCtD
Moclobemide—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.021	0.027	CbGbCtD
Moclobemide—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0201	0.0259	CbGbCtD
Moclobemide—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0199	0.0256	CbGbCtD
Moclobemide—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0194	0.0249	CbGbCtD
Moclobemide—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0193	0.0248	CbGbCtD
Moclobemide—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0182	0.0234	CbGbCtD
Moclobemide—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0177	0.0227	CbGbCtD
Moclobemide—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0175	0.0225	CbGbCtD
Moclobemide—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0175	0.0225	CbGbCtD
Moclobemide—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0167	0.0215	CbGbCtD
Moclobemide—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.016	0.0205	CbGbCtD
Moclobemide—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.016	0.0205	CbGbCtD
Moclobemide—MAOB—nerve—acquired immunodeficiency syndrome	0.00268	0.0841	CbGeAlD
Moclobemide—MAOA—nerve—acquired immunodeficiency syndrome	0.00229	0.0717	CbGeAlD
Moclobemide—MAOB—blood plasma—acquired immunodeficiency syndrome	0.00203	0.0636	CbGeAlD
Moclobemide—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00177	0.0554	CbGeAlD
Moclobemide—MAOA—blood plasma—acquired immunodeficiency syndrome	0.00173	0.0542	CbGeAlD
Moclobemide—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.00144	0.0452	CbGeAlD
Moclobemide—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00137	0.043	CbGeAlD
Moclobemide—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.00103	0.0322	CbGeAlD
Moclobemide—MAOA—retina—acquired immunodeficiency syndrome	0.000948	0.0297	CbGeAlD
Moclobemide—MAOB—digestive system—acquired immunodeficiency syndrome	0.00078	0.0244	CbGeAlD
Moclobemide—MAOB—blood—acquired immunodeficiency syndrome	0.000743	0.0233	CbGeAlD
Moclobemide—MAOB—spinal cord—acquired immunodeficiency syndrome	0.000716	0.0224	CbGeAlD
Moclobemide—MAOB—vagina—acquired immunodeficiency syndrome	0.000689	0.0216	CbGeAlD
Moclobemide—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.00068	0.0213	CbGeAlD
Moclobemide—MAOA—digestive system—acquired immunodeficiency syndrome	0.000666	0.0209	CbGeAlD
Moclobemide—MAOB—lung—acquired immunodeficiency syndrome	0.000651	0.0204	CbGeAlD
Moclobemide—CYP2C19—blood—acquired immunodeficiency syndrome	0.000648	0.0203	CbGeAlD
Moclobemide—MAOA—blood—acquired immunodeficiency syndrome	0.000634	0.0199	CbGeAlD
Moclobemide—MAOA—spinal cord—acquired immunodeficiency syndrome	0.000611	0.0191	CbGeAlD
Moclobemide—MAOB—nervous system—acquired immunodeficiency syndrome	0.000603	0.0189	CbGeAlD
Moclobemide—CYP2C19—vagina—acquired immunodeficiency syndrome	0.0006	0.0188	CbGeAlD
Moclobemide—MAOA—vagina—acquired immunodeficiency syndrome	0.000588	0.0184	CbGeAlD
Moclobemide—MAOB—central nervous system—acquired immunodeficiency syndrome	0.000581	0.0182	CbGeAlD
Moclobemide—MAOA—lung—acquired immunodeficiency syndrome	0.000556	0.0174	CbGeAlD
Moclobemide—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000555	0.0174	CbGeAlD
Moclobemide—CYP1A2—blood—acquired immunodeficiency syndrome	0.000529	0.0166	CbGeAlD
Moclobemide—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000527	0.0165	CbGeAlD
Moclobemide—MAOA—nervous system—acquired immunodeficiency syndrome	0.000515	0.0161	CbGeAlD
Moclobemide—CYP2C9—blood—acquired immunodeficiency syndrome	0.000502	0.0157	CbGeAlD
Moclobemide—MAOA—central nervous system—acquired immunodeficiency syndrome	0.000496	0.0155	CbGeAlD
Moclobemide—CYP1A2—lung—acquired immunodeficiency syndrome	0.000464	0.0145	CbGeAlD
Moclobemide—MAOB—brain—acquired immunodeficiency syndrome	0.000461	0.0144	CbGeAlD
Moclobemide—MAOB—lymph node—acquired immunodeficiency syndrome	0.000446	0.014	CbGeAlD
Moclobemide—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000396	0.0124	CbGeAlD
Moclobemide—MAOA—brain—acquired immunodeficiency syndrome	0.000393	0.0123	CbGeAlD
Moclobemide—MAOA—lymph node—acquired immunodeficiency syndrome	0.00038	0.0119	CbGeAlD
Moclobemide—CYP2D6—blood—acquired immunodeficiency syndrome	0.000377	0.0118	CbGeAlD
Moclobemide—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000306	0.00959	CbGeAlD
Moclobemide—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000294	0.00923	CbGeAlD
Moclobemide—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000268	0.0014	CcSEcCtD
Moclobemide—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.000267	0.0014	CcSEcCtD
Moclobemide—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000266	0.00139	CcSEcCtD
Moclobemide—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000265	0.00139	CcSEcCtD
Moclobemide—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000264	0.00138	CcSEcCtD
Moclobemide—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000264	0.00138	CcSEcCtD
Moclobemide—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000264	0.00138	CcSEcCtD
Moclobemide—Flatulence—Lamivudine—acquired immunodeficiency syndrome	0.000263	0.00138	CcSEcCtD
Moclobemide—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.000263	0.00138	CcSEcCtD
Moclobemide—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000263	0.00138	CcSEcCtD
Moclobemide—Tension—Lamivudine—acquired immunodeficiency syndrome	0.000262	0.00137	CcSEcCtD
Moclobemide—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000262	0.00137	CcSEcCtD
Moclobemide—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000262	0.00137	CcSEcCtD
Moclobemide—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000262	0.00137	CcSEcCtD
Moclobemide—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000261	0.00137	CcSEcCtD
Moclobemide—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000261	0.00137	CcSEcCtD
Moclobemide—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000261	0.00137	CcSEcCtD
Moclobemide—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.00026	0.00136	CcSEcCtD
Moclobemide—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.00026	0.00136	CcSEcCtD
Moclobemide—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.00026	0.00136	CcSEcCtD
Moclobemide—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000259	0.00136	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000259	0.00136	CcSEcCtD
Moclobemide—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000258	0.00135	CcSEcCtD
Moclobemide—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000258	0.00135	CcSEcCtD
Moclobemide—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000258	0.00135	CcSEcCtD
Moclobemide—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000257	0.00135	CcSEcCtD
Moclobemide—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000257	0.00135	CcSEcCtD
Moclobemide—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000256	0.00134	CcSEcCtD
Moclobemide—Rash—Didanosine—acquired immunodeficiency syndrome	0.000255	0.00134	CcSEcCtD
Moclobemide—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000255	0.00134	CcSEcCtD
Moclobemide—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000255	0.00134	CcSEcCtD
Moclobemide—Headache—Didanosine—acquired immunodeficiency syndrome	0.000254	0.00133	CcSEcCtD
Moclobemide—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000253	0.00133	CcSEcCtD
Moclobemide—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000253	0.00133	CcSEcCtD
Moclobemide—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000253	0.00132	CcSEcCtD
Moclobemide—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000253	0.00132	CcSEcCtD
Moclobemide—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000253	0.00132	CcSEcCtD
Moclobemide—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000252	0.00132	CcSEcCtD
Moclobemide—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000252	0.00132	CcSEcCtD
Moclobemide—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000251	0.00132	CcSEcCtD
Moclobemide—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000251	0.00132	CcSEcCtD
Moclobemide—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000251	0.00131	CcSEcCtD
Moclobemide—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000251	0.00131	CcSEcCtD
Moclobemide—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.00025	0.00131	CcSEcCtD
Moclobemide—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.00025	0.00131	CcSEcCtD
Moclobemide—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00025	0.00131	CcSEcCtD
Moclobemide—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000249	0.00131	CcSEcCtD
Moclobemide—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000249	0.0013	CcSEcCtD
Moclobemide—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000249	0.0013	CcSEcCtD
Moclobemide—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000248	0.0013	CcSEcCtD
Moclobemide—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000248	0.0013	CcSEcCtD
Moclobemide—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000248	0.0013	CcSEcCtD
Moclobemide—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000248	0.0013	CcSEcCtD
Moclobemide—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000247	0.00129	CcSEcCtD
Moclobemide—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000247	0.00129	CcSEcCtD
Moclobemide—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000246	0.00129	CcSEcCtD
Moclobemide—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000245	0.00128	CcSEcCtD
Moclobemide—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000245	0.00128	CcSEcCtD
Moclobemide—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000245	0.00128	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000245	0.00128	CcSEcCtD
Moclobemide—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000243	0.00127	CcSEcCtD
Moclobemide—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000243	0.00127	CcSEcCtD
Moclobemide—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000243	0.00127	CcSEcCtD
Moclobemide—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000242	0.00127	CcSEcCtD
Moclobemide—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000242	0.00127	CcSEcCtD
Moclobemide—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000242	0.00127	CcSEcCtD
Moclobemide—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000241	0.00126	CcSEcCtD
Moclobemide—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000241	0.00126	CcSEcCtD
Moclobemide—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000241	0.00126	CcSEcCtD
Moclobemide—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000241	0.00126	CcSEcCtD
Moclobemide—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000241	0.00126	CcSEcCtD
Moclobemide—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00024	0.00126	CcSEcCtD
Moclobemide—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.00024	0.00126	CcSEcCtD
Moclobemide—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.00024	0.00126	CcSEcCtD
Moclobemide—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000239	0.00125	CcSEcCtD
Moclobemide—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000239	0.00125	CcSEcCtD
Moclobemide—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000239	0.00125	CcSEcCtD
Moclobemide—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000239	0.00125	CcSEcCtD
Moclobemide—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000238	0.00125	CcSEcCtD
Moclobemide—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000237	0.00124	CcSEcCtD
Moclobemide—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000236	0.00124	CcSEcCtD
Moclobemide—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000236	0.00124	CcSEcCtD
Moclobemide—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000235	0.00123	CcSEcCtD
Moclobemide—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000234	0.00123	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000234	0.00123	CcSEcCtD
Moclobemide—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000234	0.00122	CcSEcCtD
Moclobemide—CYP2D6—brain—acquired immunodeficiency syndrome	0.000234	0.00733	CbGeAlD
Moclobemide—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000233	0.00122	CcSEcCtD
Moclobemide—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000233	0.00122	CcSEcCtD
Moclobemide—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000233	0.00122	CcSEcCtD
Moclobemide—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000233	0.00122	CcSEcCtD
Moclobemide—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000232	0.00122	CcSEcCtD
Moclobemide—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000232	0.00122	CcSEcCtD
Moclobemide—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000232	0.00122	CcSEcCtD
Moclobemide—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000232	0.00121	CcSEcCtD
Moclobemide—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000232	0.00121	CcSEcCtD
Moclobemide—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000231	0.00121	CcSEcCtD
Moclobemide—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000231	0.00121	CcSEcCtD
Moclobemide—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.00023	0.0012	CcSEcCtD
Moclobemide—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.00023	0.0012	CcSEcCtD
Moclobemide—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00023	0.0012	CcSEcCtD
Moclobemide—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000229	0.0012	CcSEcCtD
Moclobemide—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000229	0.0012	CcSEcCtD
Moclobemide—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000229	0.0012	CcSEcCtD
Moclobemide—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000228	0.0012	CcSEcCtD
Moclobemide—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000228	0.0012	CcSEcCtD
Moclobemide—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000228	0.00119	CcSEcCtD
Moclobemide—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000228	0.00119	CcSEcCtD
Moclobemide—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000227	0.00119	CcSEcCtD
Moclobemide—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000226	0.00119	CcSEcCtD
Moclobemide—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000226	0.00118	CcSEcCtD
Moclobemide—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000225	0.00118	CcSEcCtD
Moclobemide—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000225	0.00118	CcSEcCtD
Moclobemide—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000225	0.00118	CcSEcCtD
Moclobemide—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000224	0.00118	CcSEcCtD
Moclobemide—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000224	0.00117	CcSEcCtD
Moclobemide—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000223	0.00117	CcSEcCtD
Moclobemide—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000223	0.00117	CcSEcCtD
Moclobemide—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000222	0.00117	CcSEcCtD
Moclobemide—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000222	0.00116	CcSEcCtD
Moclobemide—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000222	0.00116	CcSEcCtD
Moclobemide—Rash—Stavudine—acquired immunodeficiency syndrome	0.000222	0.00116	CcSEcCtD
Moclobemide—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000222	0.00116	CcSEcCtD
Moclobemide—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000222	0.00116	CcSEcCtD
Moclobemide—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000221	0.00116	CcSEcCtD
Moclobemide—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000221	0.00116	CcSEcCtD
Moclobemide—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000221	0.00116	CcSEcCtD
Moclobemide—Headache—Stavudine—acquired immunodeficiency syndrome	0.00022	0.00115	CcSEcCtD
Moclobemide—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00022	0.00115	CcSEcCtD
Moclobemide—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.00022	0.00115	CcSEcCtD
Moclobemide—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.00022	0.00115	CcSEcCtD
Moclobemide—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.00022	0.00115	CcSEcCtD
Moclobemide—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000219	0.00115	CcSEcCtD
Moclobemide—Rash—Abacavir—acquired immunodeficiency syndrome	0.000218	0.00114	CcSEcCtD
Moclobemide—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000218	0.00114	CcSEcCtD
Moclobemide—Headache—Abacavir—acquired immunodeficiency syndrome	0.000217	0.00114	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000217	0.00113	CcSEcCtD
Moclobemide—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000216	0.00113	CcSEcCtD
Moclobemide—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000216	0.00113	CcSEcCtD
Moclobemide—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000215	0.00113	CcSEcCtD
Moclobemide—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000215	0.00112	CcSEcCtD
Moclobemide—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000214	0.00112	CcSEcCtD
Moclobemide—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000213	0.00112	CcSEcCtD
Moclobemide—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000213	0.00112	CcSEcCtD
Moclobemide—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000212	0.00111	CcSEcCtD
Moclobemide—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000212	0.00111	CcSEcCtD
Moclobemide—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000212	0.00111	CcSEcCtD
Moclobemide—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000211	0.00111	CcSEcCtD
Moclobemide—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000211	0.00111	CcSEcCtD
Moclobemide—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.00021	0.0011	CcSEcCtD
Moclobemide—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00021	0.0011	CcSEcCtD
Moclobemide—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000209	0.0011	CcSEcCtD
Moclobemide—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000209	0.0011	CcSEcCtD
Moclobemide—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000209	0.00109	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000208	0.00109	CcSEcCtD
Moclobemide—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000207	0.00108	CcSEcCtD
Moclobemide—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000207	0.00108	CcSEcCtD
Moclobemide—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000206	0.00108	CcSEcCtD
Moclobemide—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000205	0.00108	CcSEcCtD
Moclobemide—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000205	0.00107	CcSEcCtD
Moclobemide—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000204	0.00107	CcSEcCtD
Moclobemide—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000204	0.00107	CcSEcCtD
Moclobemide—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000204	0.00107	CcSEcCtD
Moclobemide—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000204	0.00107	CcSEcCtD
Moclobemide—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000203	0.00107	CcSEcCtD
Moclobemide—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000203	0.00106	CcSEcCtD
Moclobemide—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000203	0.00106	CcSEcCtD
Moclobemide—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000202	0.00106	CcSEcCtD
Moclobemide—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000201	0.00105	CcSEcCtD
Moclobemide—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000201	0.00105	CcSEcCtD
Moclobemide—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000199	0.00104	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000199	0.00104	CcSEcCtD
Moclobemide—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000197	0.00103	CcSEcCtD
Moclobemide—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000197	0.00103	CcSEcCtD
Moclobemide—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000196	0.00103	CcSEcCtD
Moclobemide—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000196	0.00103	CcSEcCtD
Moclobemide—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000196	0.00102	CcSEcCtD
Moclobemide—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000195	0.00102	CcSEcCtD
Moclobemide—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000195	0.00102	CcSEcCtD
Moclobemide—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000194	0.00102	CcSEcCtD
Moclobemide—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000194	0.00102	CcSEcCtD
Moclobemide—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000194	0.00102	CcSEcCtD
Moclobemide—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000193	0.00101	CcSEcCtD
Moclobemide—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000193	0.00101	CcSEcCtD
Moclobemide—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000193	0.00101	CcSEcCtD
Moclobemide—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000192	0.00101	CcSEcCtD
Moclobemide—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000192	0.001	CcSEcCtD
Moclobemide—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.00019	0.000996	CcSEcCtD
Moclobemide—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.00019	0.000994	CcSEcCtD
Moclobemide—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000189	0.000989	CcSEcCtD
Moclobemide—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000188	0.000987	CcSEcCtD
Moclobemide—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000188	0.000986	CcSEcCtD
Moclobemide—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000188	0.000985	CcSEcCtD
Moclobemide—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000188	0.000984	CcSEcCtD
Moclobemide—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000187	0.00098	CcSEcCtD
Moclobemide—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000187	0.000978	CcSEcCtD
Moclobemide—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000184	0.000966	CcSEcCtD
Moclobemide—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000184	0.000963	CcSEcCtD
Moclobemide—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000182	0.000953	CcSEcCtD
Moclobemide—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000182	0.000952	CcSEcCtD
Moclobemide—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000182	0.000951	CcSEcCtD
Moclobemide—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000181	0.000947	CcSEcCtD
Moclobemide—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000181	0.000947	CcSEcCtD
Moclobemide—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.00018	0.000942	CcSEcCtD
Moclobemide—Rash—Indinavir—acquired immunodeficiency syndrome	0.000179	0.000939	CcSEcCtD
Moclobemide—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000179	0.000938	CcSEcCtD
Moclobemide—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000178	0.000935	CcSEcCtD
Moclobemide—Headache—Indinavir—acquired immunodeficiency syndrome	0.000178	0.000933	CcSEcCtD
Moclobemide—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000178	0.00093	CcSEcCtD
Moclobemide—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000176	0.000921	CcSEcCtD
Moclobemide—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000173	0.000908	CcSEcCtD
Moclobemide—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000173	0.000904	CcSEcCtD
Moclobemide—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000171	0.000895	CcSEcCtD
Moclobemide—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000171	0.000893	CcSEcCtD
Moclobemide—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00017	0.00089	CcSEcCtD
Moclobemide—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000169	0.000887	CcSEcCtD
Moclobemide—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000169	0.000886	CcSEcCtD
Moclobemide—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000169	0.000885	CcSEcCtD
Moclobemide—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000168	0.000882	CcSEcCtD
Moclobemide—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000168	0.000881	CcSEcCtD
Moclobemide—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000164	0.00086	CcSEcCtD
Moclobemide—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000163	0.000856	CcSEcCtD
Moclobemide—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000163	0.000852	CcSEcCtD
Moclobemide—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000162	0.000849	CcSEcCtD
Moclobemide—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000162	0.000848	CcSEcCtD
Moclobemide—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000162	0.000848	CcSEcCtD
Moclobemide—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000161	0.000843	CcSEcCtD
Moclobemide—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00016	0.000836	CcSEcCtD
Moclobemide—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000157	0.000823	CcSEcCtD
Moclobemide—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000157	0.00082	CcSEcCtD
Moclobemide—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.00082	CcSEcCtD
Moclobemide—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000154	0.000809	CcSEcCtD
Moclobemide—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000153	0.0008	CcSEcCtD
Moclobemide—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000151	0.000792	CcSEcCtD
Moclobemide—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000151	0.000792	CcSEcCtD
Moclobemide—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00015	0.000785	CcSEcCtD
Moclobemide—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00015	0.000784	CcSEcCtD
Moclobemide—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000149	0.000782	CcSEcCtD
Moclobemide—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000149	0.00078	CcSEcCtD
Moclobemide—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000145	0.000762	CcSEcCtD
Moclobemide—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000144	0.000756	CcSEcCtD
Moclobemide—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000144	0.000756	CcSEcCtD
Moclobemide—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000144	0.000755	CcSEcCtD
Moclobemide—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000143	0.000751	CcSEcCtD
Moclobemide—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000141	0.00074	CcSEcCtD
Moclobemide—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000139	0.000727	CcSEcCtD
Moclobemide—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.000721	CcSEcCtD
Moclobemide—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000137	0.00072	CcSEcCtD
Moclobemide—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000137	0.000716	CcSEcCtD
Moclobemide—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.000712	CcSEcCtD
Moclobemide—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000679	CcSEcCtD
